Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.19M Sell
601,005
-39,005
-6% -$217K 2.83% 9
2026
Q1
$2.45M Buy
640,010
+354,036
+124% +$1.57M 2.01% 18
2025
Q4
$1.3M Sell
285,974
-76,479
-21% -$392K 1.11% 37
2025
Q3
$2.22M Buy
362,453
+3,999
+1% +$25.3K 1.99% 18
2025
Q2
$2.32M Buy
358,454
+97,698
+37% +$526K 2.33% 14
2025
Q1
$1.38M Buy
+260,756
New +$1.78M 1.56% 25

Other funds holding TBI

Peapod Lane Capital's TBI Position: Q2 2026 in Review

Peapod Lane Capital reduced its Trueblue (TBI) stake by 6.1% in Q2 2026, selling an estimated $217K and leaving 601,005 shares worth $4.19M. The position accounts for 2.83% of the portfolio, ranked #9.

Peapod Lane Capital first reported a position in TBI in Q1 2025 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Peapod Lane Capital held 601,005 shares of Trueblue worth $4.19M as of Q2 2026.
  • Peapod Lane Capital sold 39,005 Trueblue shares in Q2 2026, an estimated $217K.
  • Trueblue made up 2.83% of Peapod Lane Capital's portfolio in Q2 2026, its #9 holding.
  • Peapod Lane Capital first reported a position in Trueblue in Q1 2025 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.